Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
Analysis of revenue contributions from different manufacturers in the market.
Tuberculosis Vaccines Market
The tuberculosis vaccines market is a crucial segment of the life sciences industry. This industry deals with developing and distributing BCG vaccines to cure TB worldwide. These vaccines are available for different age groups consisting of pediatrics and adults. The BCG vaccines are developed using a weak a strain of bacteria similar to tuberculosis. BCG vaccines offer additional protection against non-includingycobacterial infections such as leprosy and Buruli ulcer. The ongoing research activities associated with developing a TB vaccine with 100% efficacy is an integral factor of the industrial growth. This market is likely to rise significantly with the growth of the pharmaceutical industry around the globe.
The rising incidences of paratuberculosis among small children and adults in various parts of the world have boosted market growth. Also, the growing demand for viral vector vaccines and recombinant protein vaccines, along with numerous developments related to attenuated vaccines, is likely to foster industrial expansion. Moreover, the growing application of these vaccines in hospitals and clinics, along with the availability of BCG therapies in online and offline platforms is expected to drive the growth of the tuberculosis vaccines market.
The research activities associated with recombinant subunit vector vaccines, along with developments in M72/AS01E (M72), are expected to create ample growth opportunities for the market players in the future. In May 2023, Zendal collaborated with IAVI. This collaboration is done to develop a TB vaccine with high efficacy.
Download
Order Databook
Actionable Solutions
